Complications of gastrectomy following CPT-11 based neoadjuvant chemotherapy for gastric cancer

被引：1
|
作者：
Marcus, SG
Cohen, D
Lin, K
Wong, K
Thompson, S
Rothberger, A
Potmesil, M
Hiotis, S
Newman, E
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83984-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A789 / A789
页数：1
相关论文
共 50 条
  • [41] Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer
    Teoule, Patrick
    Trojan, Joerg
    Bechstein, Wolf
    Woeste, Guido
    DIGESTIVE SURGERY, 2015, 32 (04) : 229 - 237
  • [42] Efficacy analyses of a randomized phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advanced or recurrent gastric cancer refractory to prior S-1 chemotherapy
    Inagaki, Hitoshi
    Nishikawa, Kazuhiro
    Fujitani, Kazumasa
    Sugimoto, Naotoshi
    Shigematsu, Tadashi
    Ishiguro, Tohru
    Tsuburaya, Akira
    Nakamura, Masato
    Nashimoto, Atsushi
    Yamane, Takao
    Yamada, Makoto
    Imano, Motohiro
    Iijima, Shohei
    Oka, Yoshio
    Kataoka, Masato
    Hironaka, Shuichi
    Andoh, Hideaki
    Morita, Satoshi
    Sakamoto, Junichi
    Tsujinaka, Toshimasa
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [43] Irinotecan (CPT-11) metabolism and disposition in cancer patients
    Sparreboom, A
    de Jonge, MJA
    de Bruijn, P
    Brouwer, E
    Nooter, K
    Loos, WJ
    van Alphen, RJ
    Mathijssen, RHJ
    Stoter, G
    Verweij, J
    CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2747 - 2754
  • [44] NCI to test CPT-11 and oxaliplatin for colorectal cancer
    不详
    CANCER PRACTICE, 1999, 7 (06) : 276 - 276
  • [45] Irinotecan (CPT-11) and cisplatin as first-line chemotherapy in advanced ovarian cancer.
    Sugiyama, T
    Noda, K
    Yakushiji, M
    Kamura, T
    ANNALS OF ONCOLOGY, 2000, 11 : 86 - 86
  • [46] Combination therapy with S-1 and irinotecan (CPT-11) for advanced or recurrent gastric cancer
    Takiuchi, Hiroya
    GASTRIC CANCER, 2009, 12 : 55 - 59
  • [47] Biweekly administration regimen of docetaxel combined with CPT-11 in patients with inoperable or recurrent gastric cancer
    Takashi Yoshioka
    Yuh Sakata
    Masanori Terashima
    Kouji Sekikawa
    Makio Gamoh
    Yasushi Mitachi
    Soh Saitoh
    Ryunosuke Kanamaru
    Gastric Cancer, 2003, 6 (3) : 153 - 158
  • [48] The impact on survival of CPT-11 as third-line or later treatment in advanced gastric cancer
    Makiyama, A.
    Arimizu, K.
    Hirano, G.
    Makiyama, C.
    Matsushita, Y.
    Shirakawa, T.
    Ohmura, H.
    Komoda, M.
    Uchino, K.
    Inadomi, K.
    Kusaba, H.
    Shinohara, Y.
    Kuwayama, M.
    Kajitani, T.
    Esaki, T.
    Baba, E.
    ANNALS OF ONCOLOGY, 2016, 27 : 51 - 51
  • [49] Combination therapy with S-1 and irinotecan (CPT-11) for advanced or recurrent gastric cancer
    Hiroya Takiuchi
    Gastric Cancer, 2009, 12 : 55 - 59
  • [50] Adenoviral expression of IkBa super-repressor enhances efficacy of 5-FU and CPT-11 chemotherapy in human gastric cancer
    Camp, ER
    Mackay, S
    Minnich, D
    Li, J
    Brank, A
    Lind, DS
    Moldawer, L
    Hochwald, S
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (03) : S77 - S77
12345